Cargando…
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera
Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by aberrant myeloid lineage hematopoiesis with excessive red blood cell and pro-inflammatory cytokine production. Patients with PV present with a range of thrombotic and hemorrhagic symptoms that affect quality of life and reduce...
Autores principales: | Benevolo, Giulia, Marchetti, Monia, Melchio, Remo, Beggiato, Eloise, Sartori, Chiara, Biolé, Carlo Alberto, Rapezzi, Davide, Bruno, Benedetto, Milan, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676644/ https://www.ncbi.nlm.nih.gov/pubmed/38025519 http://dx.doi.org/10.2147/VHRM.S429995 |
Ejemplares similares
-
Can pegylated interferon improve the outcome of polycythemia vera patients?
por: Crisà, Elena, et al.
Publicado: (2017) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo, Giulia, et al.
Publicado: (2021) -
When hemolysis masks polycythemia vera
por: Derrieux, Coralie, et al.
Publicado: (2019) -
Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
por: Accurso, Vincenzo, et al.
Publicado: (2020) -
Rapidly progressed aortic stenosis in a patient with previous diagnosis of polycythemia vera and post‐polycythemia vera myelofibrosis
por: Kiso, Shohei, et al.
Publicado: (2016)